STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Cencora, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Cencora, Inc. (COR) filed a Form 144 reporting a proposed sale of 1,886 shares of common stock through Fidelity Brokerage Services LLC on or about 10/01/2025 for an aggregate market value of $590,846.08. The filing shows 193,877,881 shares outstanding, so the shares to be sold represent a de minimis portion of the company.

The securities were acquired on 09/30/2024 through restricted stock vesting from the issuer and the payment is recorded as compensation. The filer certifies they do not possess undisclosed material adverse information. No securities were reported sold by the filer in the prior three months.

Positive

  • Clear compliance with Rule 144 disclosure requirements, including broker and share details
  • Securities were acquired via restricted stock vesting, indicating the sale relates to compensation rather than external financing
  • Filer represents no undisclosed material information, a standard protective certification for market integrity

Negative

  • Insider selling may be perceived negatively by some investors despite the small size
  • Aggregate market value of $590,846.08 could draw attention even though it's immaterial to outstanding shares

Insights

TL;DR: Insider plans to sell a very small amount of shares acquired via compensation; immaterial to market capitalization but worth monitoring for timing.

The filing discloses a proposed sale of 1,886 shares valued at $590,846.08 against 193,877,881 shares outstanding, representing roughly 0.001% of outstanding stock. Because the shares were acquired by restricted stock vesting, the sale appears to be a routine disposition of compensation-related shares rather than a financing or distress sale. Impact on liquidity and valuation is negligible, though investors may note insider selling activity as a routine governance signal.

TL;DR: Filing meets disclosure expectations for Rule 144; representation about material nonpublic information is standard and important.

The Form 144 provides required broker details, acquisition method (restricted stock vesting), and certification regarding material nonpublic information, aligning with Rule 144 compliance. The absence of prior three-month sales and the timing relative to vesting suggest standard post-vesting liquidity, not an aggressive insider exit. From a governance standpoint, the filing demonstrates procedural transparency.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Cencora (COR) report on Form 144?

The filer reported a proposed sale of 1,886 common shares through Fidelity Brokerage with an aggregate market value of $590,846.08, approximately dated 10/01/2025.

How were the shares being sold by the filer acquired?

The shares were acquired on 09/30/2024 through restricted stock vesting from the issuer and the payment is recorded as compensation.

How large is the proposed sale relative to Cencora's outstanding shares?

The filing lists 193,877,881 shares outstanding; the 1,886 shares represent a de minimis fraction of total shares outstanding.

Did the filer report any other sales in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

Which broker will execute the sale?

The sale is listed with Fidelity Brokerage Services LLC, address shown in the filing.

Does the filer claim possession of material nonpublic information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
Cencora Inc.

NYSE:COR

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

71.49B
185.78M
4.2%
94.03%
3.17%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN